CHRONIC LYMPHOCYTIC LEUKAEMIA
Clinical trials for CHRONIC LYMPHOCYTIC LEUKAEMIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOCYTIC LEUKAEMIA trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug AZD0486 shows promise in early trial for blood cancers
Disease control Recruiting nowThis study is testing a new drug called AZD0486, either alone or with other cancer drugs, in people with certain types of blood cancers like leukemia and lymphoma. The goal is to see if the drug is safe and works against the cancer. About 408 adults will take part in this early-p…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKAEMIA
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 05:43 UTC
-
New pill shows promise against tough blood cancers
Disease control Recruiting nowThis study tests an experimental oral drug, MK-1026 (nemtabrutinib), in people with certain blood cancers like chronic lymphocytic leukemia, lymphoma, and Waldenstrom's macroglobulinemia. The goal is to see if the drug can shrink tumors and control the disease. About 490 adults w…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKAEMIA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New hope for leukemia patients with weak hearts: safer drug trial launches
Disease control Recruiting nowThis study compares a targeted drug called acalabrutinib to other standard treatments for adults with chronic lymphocytic leukemia (CLL) who also have moderate to severe heart failure. The main goal is to see if acalabrutinib causes fewer heart-related side effects. About 60 part…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKAEMIA
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
Did CAR-T cause new cancers? BMS launches transgene detective study
Knowledge-focused Recruiting nowThis study looks at tumor samples from 50 people who developed a second cancer after receiving a BMS-made CAR-T cell therapy. Researchers will test whether the original treatment's genes are present in the new tumor. The goal is to understand if the therapy played a role, not to …
Matched conditions: CHRONIC LYMPHOCYTIC LEUKAEMIA
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC